Cellular Intelligence acquires STEM-PD, a Phase 2-ready cell therapy for Parkinson's disease, from Novo Nordisk ➝
Science
manifesto
stem-pd
News
Careers
contact
Email copied
X
LI
Menu
Cellular Intelligence wordmark

We are building a future where biology is no longer destiny, but design.

Read our white paper
Micha
Breakstone, Ph.D.
Micha Breakstone, Ph.D.
CEO & co-founder
Repeat AI entrepreneur who previously built and sold Chorus.ai for $575M
Allon Klein, Ph.D.
Allon Klein, Ph.D.
Scientific Co-founder
HMS Professor; Recipient of National Academy of Sciences James Prize
Olivier
Pourquié, Ph.D.
Olivier Pourquie, Ph.D.
Scientific Co-founder
HMS/BWH Professor; Member of National Academy of Sciences & National Academy of Medicine
Arjun Raj, Ph.D.
Arjun Raj, Ph.D.
Head of Comp. Bio.
Penn Professor; Recipient of NIH Director's New Innovator Award & NIH Director’s Transformative R01 Award
Cliff Tabin, Ph.D.
Cliff Tabin, Ph.D.
Scientific Co-founder
Chair of the HMS Genetics Department; Member of National Academy of Sciences
Jay Shendure,
M.D., Ph.D.
Jay Shendure, M.D., Ph.D.
Scientific Co-founder
UW Professor, HHMI investigator; Member of National Academy of Sciences
Kristy J.Brown, Ph.D.
Chief DEV. officer
Experienced leader in platform and drug development
Nuno Mendonça, M.D.
Chief medical officer
Board-certified neurologist; Experienced clinical leader in early- and late-stage programs
Cellular Intelligence acquires STEM-PD, a Phase 2-ready cell therapy for Parkinson's disease, from Novo Nordisk ➝
Science
manifesto
stem-pd
News
Careers
contact
Email copied
X
LI
Menu